Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 3Other hematologic neoplasm 2Breast 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Other 1Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Stomach Neoplasms 2Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Nutritional Support × Gastrointestinal × Clear all
NCT05714878 2024-05-10

Multimodal Prehabilitation for Resectable Gastric Cancer

Chinese PLA General Hospital

Phase NA Completed
70 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01248299 2019-05-16

E-DIS

Centre Oscar Lambret

Phase 2 Terminated
105 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02780921 2017-01-25

PREHAB

University Hospital, Clermont-Ferrand

Phase 3 Unknown
120 enrolled
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡